Show simple item record

dc.creatorHan, Arum
dc.creatorde Figueiredo, Paul J.
dc.date.accessioned2021-06-02T22:02:03Z
dc.date.available2021-06-02T22:02:03Z
dc.date.issued2/9/2021
dc.identifier.urihttps://hdl.handle.net/1969.1/193360
dc.description.abstractThe microfluidic platform device of the claimed invention makes use of a high throughput lab-on-a-chip format to determine the functional profile of antibodies elicited by infection or vaccination against infection for any pathogen. It can be used to evaluate vaccines, evaluate whether vaccinated individuals show indices of protection, determine whether individuals display resistance or susceptibility to infection, discover new vaccine antigens, discover and test therapeutic interventions, or evaluate mechanisms of disease.en
dc.languageEN
dc.publisherUnited States. Patent and Trademark Officeen
dc.rightsPublic Domain (No copyright - United States)en
dc.rights.urihttp://rightsstatements.org/vocab/NoC-US/1.0/
dc.titleMicrofluidic platform device and method for identifying neutralizing and/or enhancing antibodies through direct functional assaysen
dc.typeUtility patenten
dc.format.digitalOriginreformatted digitalen
dc.description.countryUS
dc.contributor.assigneeTexas A&M University Systemen
dc.identifier.patentapplicationnumber15/750022
dc.date.filed8/19/2016
dc.publisher.digitalTexas A&M University. Librariesen
dc.subject.cpcprimaryB01L 3/502784
dc.subject.cpcprimaryB01L 3/0241
dc.subject.cpcprimaryG01N 33/5052
dc.subject.cpcprimaryG01N 33/5023
dc.subject.cpcprimaryB01L 2200/10
dc.subject.cpcprimaryB01L 2200/0652
dc.subject.cpcprimaryB01L 2200/0673


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record